NovaBridge Biosciences
NBP
DELAYED 1 MONTH

2 insider filings · Latest: May 30, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 2 10:46 PMCong Claire XuSVP, Clinical Development
Sale
3,494$3.94$13.8K290,154(D)

View →

May 14, 2026May 18 8:05 PMSean Wuxiong CaoDirector, Chief Business Development Officer and Director
Sale
21,399$1.99$42.6K35,073(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 30, 2026Jun 2 10:46 PMCong Claire XuSVP, Clinical Development
Option Exercise
4,079—32,637(D)

View →